Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

First-Ever Medical Technology Regrows Nerves and Stops Amputations in Diabetic Patients

By HospiMedica International staff writers
Posted on 06 Oct 2025

Chronic wounds are among the most devastating and costly complications for diabetic and trauma patients, often leading to severe infections, tissue death, and amputations. More...

Despite the global wound care market exceeding USD 22 billion, existing treatments such as wound vacs, grafts, and antimicrobial creams only manage symptoms rather than addressing underlying nerve and circulation damage. Now, a new regenerative medical technology can restore nerve function, heal tissue, and prevent amputations in patients once deemed untreatable.

Developed by Rapid Nexus (Brea, CA, USA), the patented device is the first medical technology proven to regenerate nerves and reverse chronic wounds. Unlike other products that just protect the tissue, this technology, adapted to treat advanced wounds, uses a top-down approach that rebuilds the surrounding tissue and then works its way back into the bed of the wound.

It works by targeting the root cause of tissue death — damaged nerve and vascular networks — restoring blood flow and tissue vitality from within. The approach goes beyond surface healing by combining nerve regeneration and improved circulation in a single treatment system, making it the first of its kind to actively repair rather than manage chronic wounds.

In a 2018 feasibility study, every patient previously diagnosed for amputation and treated with the technology successfully avoided limb loss. One case involved a 32-year-old diabetic mother whose leg had begun to turn necrotic; after treatment, nerve regeneration and restored blood flow allowed her to walk again.

The most recent peer-reviewed study, scheduled for publication this fall, reports dozens of biomarkers working simultaneously to trigger nerve and vascular regeneration — an outcome described as unprecedented in wound healing research. The device is currently completing FDA review and has entered clinical trials with commercial rollout expected by late 2025, thus expanding its use to hospitals, home care, and underserved regions worldwide.

“We could apply this healing approach to the whole body — and prevent countless amputations that were once seen as inevitable,” said Dr. Margaret Kalmeta, founder of Rapid Nexus. “This is about restoring human dignity, one limb at a time.”

Related Links:
Rapid Nexus


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical System
Stealth AXiS
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.